| Product Information |
DR-XY48254_PI_01.pdf
|
| Registration Number |
DR-XY48254
|
| Generic Name |
Tenofovir alafenamide (as hemifumarate)
|
| Brand Name |
Tafnext
|
| Dosage Strength |
25 mg
|
| Dosage Form |
Film Coated Tablet
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Antiviral (Nucleoside/Nucleotide Reverse Transcriptase
|
| Packaging |
White opaque HDPE container 60 cc with 33 mm neck and child-resistant plastic cap with pulp liner 33 mm containing 30 tablets (Box of 30 tablets)
|
| Manufacturer |
Hetero Labs Limited (Unit-V, Block –VB)
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Camber Pharmaceuticals, Inc.
|
| Distributor |
Camber Pharmaceuticals, Inc.
|
| Application Type |
Monitored Release (Correction)
|
| Issuance Date |
27 October 2022
|
| Expiry Date |
03 August 2027
|